Active, Not Recruiting
Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors
NCT04126070
- Conditions
- Hormone Sensitive Prostate Cancer, Metastasis Prostate Adenocarcinoma, Prostate Adenocarcinoma
- Locations
-
- University of California, San Diego La Jolla, California, United States
- H. Lee Moffitt Cancer Center Tampa, Florida, United States
- The Johns Hopkins University School of Medicine Baltimore, Maryland, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States